Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Phathom Pharmaceuticals (Nasdaq: PHAT) said members of its management team will participate in two investor conferences in April 2026: the Raymond James 2026 Biotech Innovation Symposium in New York on April 14, 2026 and the 25th Annual Needham Virtual Healthcare Conference on April 15, 2026.

Management will hold one-on-one meetings and a Needham fireside chat at 1:30 pm EDT; webcasts and recordings will be available via the company website for 90 days.

News Market Reaction – PHAT

-0.79%

-0.79% Session close to close

In the Apr 6 session, PHAT declined 0.79%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FLORHAM PARK, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, announced today that members of its management team are scheduled to participate in the following upcoming investor conferences in April:

Raymond James 2026 Biotech Innovation Symposium in New York, NY
Date: Tuesday, April 14, 2026
Management to participate in one-on-one meetings throughout the conference

25th Annual Needham Virtual Healthcare Conference
Date: Wednesday, April 15, 2026
Fireside Chat: 1:30 pm EDT
Management to participate in one-on-one meetings throughout the conference

To access the live webcast and archived recording of the event, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. Recording will be available for 90 days following the conclusion of the meeting.

About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases. Phathom has in-licensed the exclusive rights to vonoprazan, a first-in-class potassium-competitive acid blocker (PCAB) for the U.S., Europe and Canada. Phathom currently markets vonoprazan in the United States as VOQUEZNA^® (vonoprazan) tablets for the relief of heartburn associated with Non-Erosive GERD in adults, the healing and maintenance of healing of Erosive GERD in adults and relief of associated heartburn, and as part of VOQUEZNA^® DUAL PAK^® (vonoprazan tablets, amoxicillin capsules) and VOQUEZNA^® TRIPLE PAK^® (vonoprazan tablets, amoxicillin capsules, clarithromycin tablets) for the treatment of H. pylori infection in adults. For more information about Phathom, visit the company’s website at www.phathompharma.com and follow on LinkedIn and X.

MEDIA CONTACT
Nick Benedetto
1-877-742-8466
media@phathompharma.com

INVESTOR CONTACT
Eric Sciorilli
1-877-742-8466
ir@phathompharma.com

© 2026 Phathom Pharmaceuticals. All rights reserved. VOQUEZNA, VOQUEZNA DUAL PAK, VOQUEZNA TRIPLE PAK, Phathom Pharmaceuticals, and their respective logos are registered trademarks of Phathom Pharmaceuticals, Inc.

FAQ

When will Phathom Pharmaceuticals (PHAT) present at the Raymond James 2026 Biotech Innovation Symposium?

Phathom management will attend the Raymond James symposium on April 14, 2026. According to Phathom, the team will participate in one-on-one meetings throughout the conference, with no public presentation time listed in the announcement.

What time is the Phathom (PHAT) fireside chat at the 25th Annual Needham Virtual Healthcare Conference?

The Phathom fireside chat is scheduled for 1:30 pm EDT on April 15, 2026. According to Phathom, management will also conduct one-on-one meetings during the virtual conference in addition to the chat.

How can investors watch Phathom Pharmaceuticals (PHAT) presentations or webcasts from the April 2026 conferences?

Investors can access live webcasts and archived recordings via the company's News & Events site. According to Phathom, recordings will be available for 90 days following each meeting's conclusion.

Will Phathom (PHAT) hold one-on-one investor meetings at the April 2026 conferences?

Yes. Phathom management will participate in one-on-one meetings at both April conferences. According to Phathom, these investor meetings occur throughout the Raymond James and Needham events.

Where is the Raymond James 2026 Biotech Innovation Symposium where Phathom (PHAT) will attend?

The Raymond James 2026 Biotech Innovation Symposium takes place in New York, NY on April 14, 2026. According to Phathom, its management team will be present for meetings during the in-person conference.